Form 4: HealthStream SVP Acquires 2,911 Restricted Share Units
Insider Transaction Report
HealthStream Senior Vice President Michael Scott McQuigg was granted 2,911 restricted share units, vesting over four years.
Summary
- Michael Scott McQuigg, Senior Vice President of HealthStream Inc. (HSTM), acquired 2,911 Restricted Share Units (RSUs) on March 18, 2026.
- Each RSU represents the contingent right to receive one share of common stock upon vesting.
- The RSUs are subject to a four-year vesting schedule, contingent upon continued service.
- The vesting schedule is as follows: 15% vest on March 18, 2027; 20% vest on March 18, 2028; 30% vest on March 18, 2029; and the remaining 35% vest on March 18, 2030.
- Following this transaction, Mr. McQuigg beneficially owns 30,954 shares of common stock directly and 2,911 derivative securities (RSUs) directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive indicator of management's continued alignment with shareholder interests through long-term equity incentives, reflecting standard compensation practices.
Positives
- The grant of Restricted Share Units aligns the Senior Vice President's long-term interests with those of shareholders, incentivizing sustained company performance.
- Increased insider equity ownership demonstrates management's commitment to the company's future.
Negatives
- The RSUs do not provide immediate cash value to the recipient.
- The vesting schedule ties a significant portion of compensation to future service, which could be forfeited if employment ceases before vesting.
Risks
- The value of the RSUs upon vesting is dependent on the future market price of HealthStream's common stock, introducing market risk.
- Forfeiture risk exists if the reporting person's service to the company terminates prior to the vesting dates.
Future Outlook
The multi-year vesting schedule for the Restricted Share Units indicates a long-term incentive structure designed to retain key management and align their performance with the company's sustained growth and shareholder value creation over the next four years.
Industry Context
StockSavvy.ai notes that RSU grants are a common form of long-term incentive compensation in the technology and healthcare IT sectors, aligning executive interests with shareholder value over time. This practice is standard for retaining experienced leadership and motivating performance in competitive markets.
Comparison to Industry Standards
- StockSavvy.ai observes that multi-year vesting schedules, such as the four-year plan for these RSUs, are standard practice across many publicly traded companies, including peers in the healthcare technology space like Cerner (now Oracle Health) or Allscripts Healthcare Solutions (now Veradigm).
- This structure aims to retain talent and incentivize sustained performance, a common strategy seen in executive compensation packages globally.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of management's interests with long-term company performance.
- Employees (specifically the Senior Vice President): Receives long-term equity compensation, incentivizing continued service and performance.
Next Steps
- Vesting of 15% of RSUs on March 18, 2027.
- Vesting of 20% of RSUs on March 18, 2028.
- Vesting of 30% of RSUs on March 18, 2029.
- Vesting of 35% of RSUs on March 18, 2030.
Key Dates
| Date | Description |
|---|---|
| 03/18/2026 | Date of grant for 2,911 Restricted Share Units to Michael Scott McQuigg. |
| 03/24/2026 | Date the Form 4 filing was signed by M. Scott McQuigg. |
| 03/18/2027 | First vesting date for 15% of the Restricted Share Units. |
| 03/18/2028 | Second vesting date for 20% of the Restricted Share Units. |
| 03/18/2029 | Third vesting date for 30% of the Restricted Share Units. |
| 03/18/2030 | Final vesting date for 35% of the Restricted Share Units. |
Recommendation
holdThis Form 4 filing reports a routine grant of restricted share units to a Senior Vice President, which is a standard component of executive compensation. While it indicates continued management alignment, it does not present new information significant enough to alter an investment thesis or warrant a change in recommendation based solely on this filing.
Keywords
HealthStream, HSTM, SEC Form 4, Insider Transaction, Restricted Share Units, Equity Compensation, Michael Scott McQuigg, Senior Vice President
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.